SCHEMBL28191982

SCHEMBL28191982

CC(CC(=O)OF)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LTB4R Q15722 1/20 0.48
LTB4R2 Q9NPC1 1/20 0.48
HPGD P15428 3/20 0.48
ALDH1A1 P00352 2/20 0.48
FFAR1 O14842 2/20 0.47
CYP3A4 P08684 1/20 0.46
CYP2C19 P33261 1/20 0.46
RAB9A P51151 1/20 0.46
POLB P06746 2/20 0.46
BCHE P06276 1/20 0.45
TAAR1 Q96RJ0 2/20 0.44
TRPA1 O75762 2/20 0.43
FFAR4 Q5NUL3 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9909362 0.83 HPGD (0.56) LTB4RLTB4R2HPGDALDH1A1FFAR1
SCHEMBL1894982 0.83 HPGD (0.56) LTB4RLTB4R2HPGDALDH1A1FFAR1
SCHEMBL28115672 0.81 ALDH1A1 (0.51) LTB4RLTB4R2HPGDALDH1A1FFAR1
SCHEMBL27476164 0.81 TAAR1 (0.48) LTB4RLTB4R2HPGDALDH1A1FFAR1
SCHEMBL27982253 0.81 BCHE (0.49) LTB4RLTB4R2HPGDALDH1A1FFAR1
SCHEMBL7056829 0.81 LTB4R (0.48) LTB4RLTB4R2HPGDALDH1A1FFAR1
SCHEMBL11442263 0.81 TSHR (0.58) LTB4RLTB4R2HPGDALDH1A1FFAR1
SCHEMBL23027267 0.80 LTB4R (0.54) LTB4RLTB4R2HPGDALDH1A1FFAR1
SCHEMBL13572924 0.80 LTB4R (0.54) LTB4RLTB4R2HPGDALDH1A1FFAR1
SCHEMBL30688108 0.80 LTB4R (0.54) LTB4RLTB4R2HPGDALDH1A1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110088096-A Piperidine derivatives as inhibitors of ubiquitin-specific protease 7 阿尔麦克探索有限公司 2019-08-02 CN disclosed
CN-109790146-A Medical compounds 阿尔麦克探索有限公司 2019-05-21 CN disclosed
CN-107406451-A Pyrrolopyrimidines and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors 福马治疗股份有限公司 2017-11-28 CN disclosed